In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Novostia raises CHF6.5mm via seed round

Executive Summary

Novostia SA raised CHF6.5mm ($6.5mm) in its seed financing to undisclosed private investors. The company will use the proceeds to move its disruptive aortic and mitral heart valve into the clinic. Its valve incorporates a biocompatible polymer, is more durable, and doesn’t require that patients take life-long anticoagulants as is the case with other valve technologies.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register